logo
Cure of myeloma: hype or reality?
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications
Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience
Second allografts for relapsed hematologic malignancies: feasibility of using a different donor
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler)
Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD/SCID mice
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning
Analysis of haematopoietic chimaerism by quantitative real-time polymerase chain reaction
Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study
Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation
What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience
Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation
Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma
Post transplant lymphoproliferative disease: detection of tumor by Tc99m sestaMIBI and treatment with rituximab
Clinical bone marrow and blood stem cell transplantation
Corrigenda
Corrigenda
Erratum